Matt Goldman | CureTalks
Matt Goldman was diagnosed with multiple myeloma in May 2011 at the age of 49. He has had two relapses and has been on 5 different lines of treatment. Matt started on immunotherapy following a relapse and has been on the same regimen since then. Matt is currently in complete response but must continue with his regimen of a monthly immunotherapy infusion, a daily oral chemo and steroids. Matt had his stem cells collected in December 2011 but has no plans to undergo a stem cell transplant. Matt’s kidneys were damaged by the myeloma, but a combination of exercise and nutrition, along with stable myeloma have helped to keep his kidneys functioning. Matt worked full time from diagnosis until July 2017 when he decided to retire to focus on his health, family, and to rebuild his energy and strength. Matt lives in Long Beach, CA with his wife Leslie. He has a blog that documents his journey, www.mattvsmyeloma.com and is also on twitter at @mpg61.
Related Talks
Myeloma 2017 – Year in Review with MMRF
The MMRF is pioneering precision medicine initiatives in multiple myeloma. This would help match patients to the most effective therapies based on their…
Webinar: Climbing Mount Kilimanjaro for the MMRF with Myeloma Patient Advocate Matt Goldman
In February 2017, along with 5 other patients and 10 individuals who have had their lives impacted by myeloma, Matt Goldman climbed Mt.…
Multiple Myeloma: Minimal Residual Disease Testing as an End Point Treatment
Most multiple myeloma patients, even those in complete response, may show signs of relapse at some point of time. So, testing and quantifying…
The MMRF Precision Medicine Model – How Close to Multiple Myeloma Cure Are We?
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated…
Immunotherapy Advances in Multiple Myeloma
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody…